Cite
HARVARD Citation
Hasselblatt, M. et al. (2022). SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome. American journal of surgical pathology. pp. 1277-1283. [Online].